TheraB, a life sciences spin-out of Michigan State University, has received $150,000 in pre-seed funding to boost the fresh startup’s efforts to tackle infant jaundice.
The funding, which came via medtech early-stage investor Quantum Medical Concepts, will be used to advance product development.
The US-based spin-out is developing the Snuglit portable phototherapy blanket, which provides the blue light newborn require to breakdown bilburin molecules, a blood pigment which causes jaundice.
Ryan Jankovic, CEO of TheraB, said: “We’ve worked to make SnugLit easy to use so parents can have the treatment they need for their infant and also be able to conduct their daily activities. The blanket can be used both at home and in the home for mild cases.”
